Preclinical investigation of patient-derived cervical cancer organoids for precision medicine.

Hyang Sook Seol Ju Hee Oh Eunhye Choi SangMin Kim Hyunki Kim Eun Ji Nam

Published in: Journal of gynecologic oncology (2022)

Our results showed that patient-derived cervical cancer organoids can be used as a platform for drug and radiation sensitivity testing. These findings suggest that patient-derived cervical cancer organoids could be used as a personalized medicine platform and may provide the best treatment options for patients with various subtypes of cervical cancer.

Keyphrases

high throughput
stem cells
induced pluripotent stem cells
emergency department
mesenchymal stem cells
bone marrow
radiation induced
drug induced